ERNA vs LIN · P/E 0.0, rev $582.0K vs P/E 34, rev $33.99B
Eterna Therapeutics Inc (ERNA) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the ERNA and LIN stock pages for the full models.
Not investment advice.